HEADER TRANSFERASE 09-JUN-06 2DRJ TITLE XRAY STRUCTURE OF ALPHA-2,3/8-SIALYLTRANSFERASE CSTII F91Y MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-2,3/8-SIALYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SIALYLTRANSFERASE RESIDUES 1-259; COMPND 5 SYNONYM: ALPHA-2,3-/2,8-SIALYLTRANSFERASE; COMPND 6 EC: 2.4.99.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CAMPYLOBACTER JEJUNI; SOURCE 3 ORGANISM_TAXID: 197; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET KEYWDS MIXED ALPHA/BETA, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.P.C.CHIU,N.C.J.STRYNADKA REVDAT 6 25-DEC-24 2DRJ 1 REMARK LINK REVDAT 5 25-OCT-23 2DRJ 1 REMARK REVDAT 4 10-NOV-21 2DRJ 1 REMARK SEQADV LINK REVDAT 3 11-OCT-17 2DRJ 1 REMARK REVDAT 2 24-FEB-09 2DRJ 1 VERSN REVDAT 1 24-APR-07 2DRJ 0 JRNL AUTH A.AHARONI,K.THIEME,C.P.C.CHIU,S.BUCHINI,L.L.LAIRSON,H.CHEN, JRNL AUTH 2 N.C.J.STRYNADKA,W.W.WAKARCHUK,S.G.WITHERS JRNL TITL HIGH-THROUGHPUT SCREENING METHODOLOGY FOR THE DIRECTED JRNL TITL 2 EVOLUTION OF GLYCOSYLTRANSFERASES JRNL REF NAT.METHODS V. 3 609 2006 JRNL REFN ISSN 1548-7091 JRNL PMID 16862130 JRNL DOI 10.1038/NMETH899 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 12793 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 685 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 647 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.1730 REMARK 3 BIN FREE R VALUE SET COUNT : 33 REMARK 3 BIN FREE R VALUE : 0.2760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1949 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 92 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.92000 REMARK 3 B22 (A**2) : -1.92000 REMARK 3 B33 (A**2) : 3.85000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.305 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.242 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.144 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.545 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.895 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2053 ; 0.021 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2775 ; 1.788 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 230 ; 7.255 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 105 ;34.126 ;24.952 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 349 ;17.411 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 3 ;17.049 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 293 ; 0.125 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1561 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 932 ; 0.223 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1393 ; 0.322 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 129 ; 0.197 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 39 ; 0.211 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.199 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1203 ; 1.187 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1878 ; 2.033 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 991 ; 3.029 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 897 ; 4.183 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DRJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000025758. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.514 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13458 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 65.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.18500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1RO7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TEA PH 7.5, 20% PEG 400, 10% REMARK 280 ISOPROPANOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 283K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 58.32650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 58.32650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 22.04300 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 58.32650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 58.32650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 22.04300 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 58.32650 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 58.32650 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 22.04300 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 58.32650 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 58.32650 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 22.04300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A TETRAMER GENERATED FROM THE REMARK 300 MOLECULE IN THE ASYMMETRIC UNIT BY THE OPERATIONS: -X,-Y,Z; -Y,X,Z; REMARK 300 Y,-X,Z. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 GLN A 157 REMARK 465 ASN A 158 REMARK 465 GLY A 159 REMARK 465 SER A 160 REMARK 465 SER A 161 REMARK 465 TYR A 162 REMARK 465 ALA A 163 REMARK 465 PHE A 164 REMARK 465 ASP A 165 REMARK 465 PHE A 178 REMARK 465 LYS A 179 REMARK 465 ASN A 180 REMARK 465 ASP A 181 REMARK 465 ASN A 182 REMARK 465 SER A 183 REMARK 465 HIS A 184 REMARK 465 TYR A 185 REMARK 465 ILE A 186 REMARK 465 GLY A 187 REMARK 465 HIS A 188 REMARK 465 SER A 189 REMARK 465 LYS A 256 REMARK 465 ASN A 257 REMARK 465 ILE A 258 REMARK 465 ASN A 259 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 31 O3A CSF A 1001 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 23 -25.33 75.62 REMARK 500 ASN A 31 -125.04 48.32 REMARK 500 GLN A 32 43.47 -88.82 REMARK 500 ASP A 154 -32.24 -130.52 REMARK 500 PHE A 155 72.94 65.40 REMARK 500 LYS A 167 64.93 -66.98 REMARK 500 PRO A 176 48.29 -63.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 23 ASP A 24 147.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CSF A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IPA A 2002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RO7 RELATED DB: PDB REMARK 900 RELATED ID: 1RO8 RELATED DB: PDB DBREF 2DRJ A 1 259 UNP Q9LAK3 Q9LAK3_CAMJE 1 259 SEQADV 2DRJ GLY A -2 UNP Q9LAK3 EXPRESSION TAG SEQADV 2DRJ SER A -1 UNP Q9LAK3 EXPRESSION TAG SEQADV 2DRJ HIS A 0 UNP Q9LAK3 EXPRESSION TAG SEQADV 2DRJ SER A 53 UNP Q9LAK3 ILE 53 ENGINEERED MUTATION SEQADV 2DRJ TYR A 91 UNP Q9LAK3 PHE 91 ENGINEERED MUTATION SEQADV 2DRJ GLY A 222 UNP Q9LAK3 GLU 222 ENGINEERED MUTATION SEQRES 1 A 262 GLY SER HIS MET LYS LYS VAL ILE ILE ALA GLY ASN GLY SEQRES 2 A 262 PRO SER LEU LYS GLU ILE ASP TYR SER ARG LEU PRO ASN SEQRES 3 A 262 ASP PHE ASP VAL PHE ARG CYS ASN GLN PHE TYR PHE GLU SEQRES 4 A 262 ASP LYS TYR TYR LEU GLY LYS LYS CYS LYS ALA VAL PHE SEQRES 5 A 262 TYR ASN PRO SER LEU PHE PHE GLU GLN TYR TYR THR LEU SEQRES 6 A 262 LYS HIS LEU ILE GLN ASN GLN GLU TYR GLU THR GLU LEU SEQRES 7 A 262 ILE MET CYS SER ASN TYR ASN GLN ALA HIS LEU GLU ASN SEQRES 8 A 262 GLU ASN TYR VAL LYS THR PHE TYR ASP TYR PHE PRO ASP SEQRES 9 A 262 ALA HIS LEU GLY TYR ASP PHE PHE LYS GLN LEU LYS ASP SEQRES 10 A 262 PHE ASN ALA TYR PHE LYS PHE HIS GLU ILE TYR PHE ASN SEQRES 11 A 262 GLN ARG ILE THR SER GLY VAL TYR MET CYS ALA VAL ALA SEQRES 12 A 262 ILE ALA LEU GLY TYR LYS GLU ILE TYR LEU SER GLY ILE SEQRES 13 A 262 ASP PHE TYR GLN ASN GLY SER SER TYR ALA PHE ASP THR SEQRES 14 A 262 LYS GLN LYS ASN LEU LEU LYS LEU ALA PRO ASN PHE LYS SEQRES 15 A 262 ASN ASP ASN SER HIS TYR ILE GLY HIS SER LYS ASN THR SEQRES 16 A 262 ASP ILE LYS ALA LEU GLU PHE LEU GLU LYS THR TYR LYS SEQRES 17 A 262 ILE LYS LEU TYR CYS LEU CYS PRO ASN SER LEU LEU ALA SEQRES 18 A 262 ASN PHE ILE GLY LEU ALA PRO ASN LEU ASN SER ASN PHE SEQRES 19 A 262 ILE ILE GLN GLU LYS ASN ASN TYR THR LYS ASP ILE LEU SEQRES 20 A 262 ILE PRO SER SER GLU ALA TYR GLY LYS PHE SER LYS ASN SEQRES 21 A 262 ILE ASN HET CSF A1001 42 HET IPA A2001 4 HET IPA A2002 4 HETNAM CSF CYTIDINE-5'-MONOPHOSPHATE-3-FLUORO-N-ACETYL-NEURAMINIC HETNAM 2 CSF ACID HETNAM IPA ISOPROPYL ALCOHOL HETSYN CSF CMP-3FNEUAC HETSYN IPA 2-PROPANOL FORMUL 2 CSF C20 H30 F N4 O16 P FORMUL 3 IPA 2(C3 H8 O) FORMUL 5 HOH *92(H2 O) HELIX 1 1 GLY A 10 ILE A 16 5 7 HELIX 2 2 ASP A 17 LEU A 21 5 5 HELIX 3 3 GLN A 32 GLU A 36 5 5 HELIX 4 4 ASN A 51 SER A 53 5 3 HELIX 5 5 LEU A 54 ASN A 68 1 15 HELIX 6 6 ASN A 88 THR A 94 1 7 HELIX 7 7 THR A 94 PHE A 99 1 6 HELIX 8 8 GLY A 105 LYS A 110 1 6 HELIX 9 9 LEU A 112 ASN A 127 1 16 HELIX 10 10 THR A 131 LEU A 143 1 13 HELIX 11 11 GLN A 168 ALA A 175 1 8 HELIX 12 12 LYS A 190 LYS A 205 1 16 HELIX 13 13 LEU A 216 ILE A 221 1 6 HELIX 14 14 SER A 247 SER A 255 1 9 SHEET 1 A 7 HIS A 103 LEU A 104 0 SHEET 2 A 7 GLU A 72 CYS A 78 1 N CYS A 78 O HIS A 103 SHEET 3 A 7 LYS A 44 TYR A 50 1 N VAL A 48 O MET A 77 SHEET 4 A 7 ASP A 26 CYS A 30 1 N VAL A 27 O LYS A 46 SHEET 5 A 7 LYS A 3 ALA A 7 1 N ILE A 5 O ASP A 26 SHEET 6 A 7 GLU A 147 SER A 151 1 O TYR A 149 N VAL A 4 SHEET 7 A 7 LYS A 207 CYS A 210 1 O TYR A 209 N ILE A 148 CISPEP 1 PHE A 155 TYR A 156 0 -15.59 SITE 1 AC1 16 GLY A 8 ASN A 9 GLY A 10 CYS A 30 SITE 2 AC1 16 ASN A 31 GLN A 32 ASN A 51 THR A 131 SITE 3 AC1 16 SER A 132 GLY A 152 ILE A 153 ASP A 154 SITE 4 AC1 16 TYR A 156 ASN A 177 HOH A2052 HOH A2084 SITE 1 AC2 3 PRO A 52 TYR A 91 VAL A 92 SITE 1 AC3 3 PHE A 126 ASN A 230 ILE A 232 CRYST1 116.653 116.653 44.086 90.00 90.00 90.00 I 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008572 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008572 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022683 0.00000